Duracrin
Duracrin is a startup headquartered in New Haven, United States, founded in 2025. It has raised at least $1.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Duracrin has raised at least $1.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Duracrin sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in New Haven
- Avridh Technologies
- CoreChain Technologies
- EVident Battery
- Noteworthy AI
- Quarry DAC
- Quarry Heme
- Quarry Thera
- Revalia Bio
- Synthesis Labs
- Valisure Enterprises
- Verustruct
Related
- Innovation profile of New Haven
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Duracrin do?
Duracrin is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Duracrin raised?
At least $1.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Duracrin based?
Duracrin is headquartered in New Haven, United States.
When was Duracrin founded?
Duracrin was founded in 2025.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.